MS News: November 2016

why-to-go-for-clinical-trials-best-treatment-for-health-issues1

Because of #DonaldTrump’s shock election in the US and his insistence on scrapping Obamacare once in office, I’ve added some sites and articles dealing with insurance etc.

Highlight!

  1. Health Insurance and Medicare
  2. Dumping Obamacare without a better plan is cruel
  3. How Trump Plan To Gut Obamacare Will Take Down Medicare
  4. ‘Trumpcare’ Proposals Could Cripple the Healthcare System
  5. Even If Donald Trump Changed The FDA Drug Approval Process, Patients Wouldn’t Benefit
  6. Repealing Obamacare Would Give A Tax Cut To Millionaires, Like Donald Trump
  7. President Trump Could Derail Obamacare By Dropping Legal Appeal
  8. Insurers use high drug costs to deter some Obamacare patients, economist says
  9. Americans are freaking out about losing Obamacare

Research

  1. ‘Rare’ Molecule in Immune System Is Common and May Be Part of What Goes Wrong in MS
  2. Let the Sun Shine (Moderately) on Your Multiple Sclerosis
  3. New Research into T-cells May Lead to Immune-based Therapies for MS, Other Diseases
  4. NIH Grant to Support Research into Role of Copper in Demyelination
  5. Gene Test May Predict Which MS Patients Will Respond to Interferon-beta Therapy
  6. University Researchers Develop Tool to Diagnose Serious Weight Loss in Patients with MS, Cancer
  7. Gene Variant Could Lead to New Treatments for Multiple Sclerosis
  8. Angiogenic factors are associated with multiple sclerosis
  9. Gene discovered to cause rare, severe neurological disease
  10. Researchers Use Stem Cells To Uncover Possible Clue To Why Myelin Repair Fails i…
  11. Neuroinflammation and Innate Immunity / Multiple Sclerosis Cluster Head, Neuroscience Research …
  12. Immune System May Harbor Natural Way of Fighting MS, Other Autoimmune Diseases
  13. Myelin May Hold Raw Material for Immunizing MS Patients Against Demyelination
  14. Multiple Sclerosis Symptom Onset May Affect Disability Progression
  15. New Study Finds Low Vitamin D Levels in Newborns Linked to Increased Risk for MS…
  16. Patients With Multiple Sclerosis Have Altered Metabolic Flexibility
  17. Study Shows Distance from the Equator Linked to Age of When a Person Develops MS
  18. Gray Matter, White Matter Ratio Predicts Multiple Sclerosis Progression
  19. MS Patients Fall Ill Earlier in World’s Northern Regions

Clinical Trials

  1. NCT01768039 – Vitamine D in Multiple Sclerosis
  2. Discovery MS Launches in North Carolina with Series of Research Efforts
  3. Research About Why Interferon Can Fail is Welcome
  4. Late-Onset MS Patients More Likely to Progress Quickly to Disability, Study Says
  5. Men and Women Seen to Differ in Genetic Susceptibility to MS and Its Progression in Study

Treatment News

  1. Innovative Multiple Sclerosis treatment receives £1m funding boost
  2. Explaining Lemtrada for Multiple Sclerosis
  3. Information Overload Precedes Lemtrada Infusions
  4. Lemtrada Targets Circulating Innate Immune Cells in RRMS Patients
  5. Trigeminal Neuralgia Treatment: PERIPHERAL NERVE STIMULATION FACIAL PAIN
  6. Relapse Management in MS [expert video]
  7. Availability of MS Therapies Provides ‘Peace of Mind’ Value to Society, Study Finds
  8. Effectiveness and Safety of DMDs Top Patient Concerns with These Therapies, Survey Says
  9. Ampyra/Fampyra for MS Patients ‘Not Recommended’ by NHS Scotland
  10. Ampyra Helps MS Patients Not Only Walk Better, But Feel Better Too, Study Reports
  11. Lioresal (baclofen)
  12. Testing Stages of Marijuana Gum to Treat Spasticity in MS Can Be Followed Online
  13. Discussing Biotin as a Treatment for Multiple Sclerosis
  14. Improvement in Preexisting Multiple Sclerosis–Related Disability with Alemtuzumab

General news

  1. 6 Tips for MS Patients, Families & Loved Ones
  2. RSNA 2016: Philips to Debut Advanced Software Applications to Evaluate Neurological Disorders
  3. Trigeminal Neuralgia Information Page
  4. Pseudobulbar Affect and other rare MS conditions
  5. MS Does Not Raise a Women’s Risk of Breast Cancer, Study Concludes
  6. 10 Multiple Sclerosis Facts You Might Find Interesting

Mental & Emotional Health

  1. Palliative Care Helps Improve Life Quality, Ease Pain of Anyone with Serious Illness
  2. MS Needle Fatigue: That Sudden, ‘I Am Not an Orange’ Feeling
  3. MS and the Art of Pretending – Beyond the Smile
  4. Confronting the Future-Tripping Fear of MS
  5. Avoiding the Black Hole of MS Depression

Diet

  1. Research on Diet and Progressive MS Highlighted in Nature Supplement
  2. 7 Multiple Sclerosis-Friendly Recipes
  3. Can diet affect the course of your MS
  4. 5 Useful Food Hacks for MS Patients

Exercise

  1. Simple Leg Exercises for Multiple Sclerosis Patients

Lifestyle

  1. Surviving the Holiday Blues Requires Conscious Effort

When You’ve Just Been Diagnosed

  1. 11 Symptoms of Multiple Sclerosis to Be Aware Of

News posted on Barts MS Blog, with thanks to Gavin Giovannoni and his team

  1. #ResearchSpeak: remyelination study suggests small positive effect
  2. #ResearchSpeak: rise of the PIRTs
  3. #ResearchSpeak: is it or is it not; that is the qu…
  4. #ResearchSpeak: MS prevention can we make it a rea…
  5. #ResearchSpeak: can we predict who will develop MS…
  6. #ResearchSpeak: the expanding MS lesion
  7. #ClinicSpeak & #ResearchSpeak: CCSVI a post-truism…
  8. #ClinicSpeak & #BrainHealth: how much more data do…
  9. #ClinicSpeak & #BrainHealth: I love my brain can y…
  10. #ClinicSpeak & #NeuroSpeak: not all immunosuppress…
  11. #ClinicSpeak & #NeuroSpeak: NEDA defines a pecking…
  12. #ClinicSpeak: personalised medicine is a confusing…
  13. #ClinicSpeak: Is progressive MS modifiable?
  14. #ClinicSpeak: what does personalised medicine mean…
  15. #NeuroSpeak: ECF Baveno presentation
  16. #GuestPost & #MSChampion: a follow-up letter from …
  17. #PoliticalSpeak & #OffLabel: help improve access t…
  18. The Guest post that would have been great Annette …
  19. NEDA
  20. How to fool the public with a clinical trial that …
  21. Major trials go unpublished
  22. Is there life still left in 1st line injectables? …
  23. Interferons verses Glatiramer Acetate
  24. Interferon Resistant EAE
  25. All things Alemtuzumab, raison d’etre?
  26. Rituximab in the switch from natalizumab
  27. Natalizumab and Fingolimod are better than the CRA…
  28. Sodium Channel blockers as a target for progressiv…
  29. Botox for MS
  30. Autoimmunity
  31. The story of the CSF
  32. Your own stem cells may not be the simple answer t…
  33. Age of Onset and latitude
  34. Aging B cells in MS
  35. The cost of treating MS
  36. Labeling myelin
  37. Antibodies and Myelin as early features of demyeli…
  38. Thinking about Walking again

Business News

  1. The 5 Best Biotech Stocks of 2016
  2. AbbVie’s Plans for ABT-555, a Novel Multiple Sclerosis Therapy
  3. Global Multiple Sclerosis Drugs Market Headed for Growth and Global Expansion by 2015 to 2021
  4. Partnership Receives $1.2M from California Initiative to Advance Precision Medicine for MS
  5. New Company Specializing in Stem Cell Platform for MS and Other Ills Raises $48.5M
  6. AXIM Biotech to Get U.S. Patent Covering All Cannabinoids in Its Chewing Gums
  7. BAS Joins with Montel Williams in Effort to Bring Cannabis Products for MS to Market
  8. Global Gamma Knife Market to expand at a CAGR of 9.0% through 2015 to 2025
  9. Pipeline Review of Trigeminal Neuralgia Market H1 2016 – Orbis Research

Videos

  1. Multiple Sclerosis and Pilates
  2. Working Out With Multiple Sclerosis
  3. Challenging Myself With Multiple Sclerosis
  4. Thriving With Multiple Sclerosis
  5. Mysteries of Multiple Sclerosis
  6. Living With MS: Switching Medications
  7. MS Stories: I Am Viable

___________________________________________________________________________________________________
© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2016. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

1 Comment

Your thoughts?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: